Literature DB >> 28328891

A license to cure?

Cathleen Lutz1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28328891      PMCID： PMC5776737          DOI： 10.1038/laban.1221

Source DB:  PubMed          Journal:  Lab Anim (NY)        ISSN： 0093-7355            Impact factor:   12.625


× No keyword cloud information.
  4 in total

1.  Licensing and distribution of research tools: National Institutes of Health perspective.

Authors:  S M Ferguson
Journal:  J Clin Pharmacol       Date:  2001-07       Impact factor: 3.126

Review 2.  Next generation sequencing and the future of genetic diagnosis.

Authors:  Katja Lohmann; Christine Klein
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 3.  Simple, Efficient CRISPR-Cas9-Mediated Gene Editing in Mice: Strategies and Methods.

Authors:  Benjamin E Low; Peter M Kutny; Michael V Wiles
Journal:  Methods Mol Biol       Date:  2016

Review 4.  Eteplirsen: First Global Approval.

Authors:  Yahiya Y Syed
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.